Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Use of Epigenetic Biomarkers for Preclinical Detection of Hepatocellular Carcinoma: Potential for Noninvasive Screening of High-Risk Populations

15 Apr 2007

Abstract excerpt

In this issue of Clinical Cancer Research , Zhang et al. ([1][1]) examined the potential for the use of epigenetic biomarkers in a noninvasive approach to early detection of hepatocellular carcinoma in a population of high-risk patients from Taiwan. Using DNA prepared from serum samples

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenetics and DNA Methylation
Share to Liver Disease Diagnosis and Treatment
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 17438087
DOI: 10.1158/1078-0432.ccr-07-0086

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

The Use of Epigenetic Biomarkers for Preclinical Detection of Hepatocellular Carcinoma: Potential for Noninvasive Screening of High-Risk PopulationsPMID 17438087Read ↗

<i>MT1M</i>and<i>MT1G</i>promoter methylation as biomarkers for hepatocellular carcinomaSemantic proximity Read ↗

Predicting Hepatocellular Carcinoma by Detection of Aberrant Promoter Methylation in Serum DNASemantic proximity Read ↗

A novel strategy for the diagnosis, prognosis, treatment, and chemoresistance of hepatocellular carcinoma: DNA methylationSemantic proximity Read ↗

Advances in Epigenetics of Hepatocellular CarcinomaSemantic proximity Read ↗

Genetic and epigenetic biomarkers in cancer diagnosis and identifying high risk populationsSemantic proximity Read ↗

Clinical promise and applications of epigenetic biomarkersSemantic proximity Read ↗

The genetic and epigenetic alterations in human hepatocellular carcinoma: a recent update.Semantic proximity Read ↗

Epigenetic Biomarkers for the Diagnosis and Treatment of Liver DiseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.